Luna Experience is a combination of Fluopyram and Tebuconazole, which provide two different modes of action. Fluopyram, belonging to a new chemical class discovered by Bayer, acts as a Succinate Dehydrogenase Inhibitor (SDHI) by blocking the energy production in the mitochondria of the fungus cell and disrupting the respiration chain. Tebuconazole acts as a demethylation inhibiter (DMI) by interfering in the process of building the structure of the fungal cell wall, ultimately inhibiting the reproduction and further growth of the fungus.